Target intelligence / Profile preview

Neisseria meningitidis capsular polysaccharide serogroup B (NmB CPS)

Target
NmB CPS
Molecular classification
Polysaccharide, Capsular polysaccharide
01

Overview

The capsular polysaccharide of Neisseria meningitidis serogroup B (NmB) is a key surface structure and virulence factor of this Gram-negative bacterium. It consists primarily of polymers made from α(2→8)-linked polysialic acid, closely mimicking human neural cell adhesion molecules. This mimicry contributes to immune evasion but also complicates vaccine development. While essential for virulence by inhibiting complement and phagocytosis, the capsule is not directly targeted by current vaccines due to safety and immunogenicity concerns. Instead, protein-based vaccines targeting other surface antigens are used.

Other names
Group B capsular polysaccharideNmB capsular polysaccharidePoly-α(2→8)-N-acetylneuraminic acidSerogroup B capsule
02

Mechanism of action

Not directly targeted by current vaccines; protein-based vaccines target other surface antigens.

03

Biological functions

Immune evasionComplement inhibitionPhagocytosis inhibitionVirulence factor
04

Disease associations

Invasive meningococcal diseaseBacterial meningitisSepsis
05

Safety considerations

Molecular mimicry with human neural cell adhesion moleculesPotential for autoimmunityPoor immunogenicity

Beyond the preview

Go deeper on Neisseria meningitidis capsular polysaccharide serogroup B (NmB CPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis capsular polysaccharide serogroup B (NmB CPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call